Identification of tumor mutations in plasma based on mutation variant frequency change (MVFC)

Identification of tumor mutations in plasma based on mutation variant frequency change (MVFC)

To overcome the dependency of strategies utilizing cell‐free DNA (cfDNA) on tissue sampling, the emergence of sequencing panels for non‐invasive mutation screening was promoted. However, cfDNA sequencing with panels still suffers from either inaccuracy or omission, and novel approaches for accuratel...

Full description

Bibliographic Details
Main Authors: Geng Chen, Fang Peng, Xiuqing Dong, Zhixiong Cai, Zhenli Li, Lei He, Jinpan Hu, Xiaoxu Deng, Yutong Guo, Liman Qiu, Yang Zhou, Jingfeng Liu, Huqin Zhang, Xiaolong Liu
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Molecular Oncology
Subjects:
cfDNA
hepatocellular carcinoma
liquid biopsy
minimum residual disease
variant frequency change
Online Access:https://doi.org/10.1002/1878-0261.13498

Internet

https://doi.org/10.1002/1878-0261.13498

Similar Items